Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -144.85M | -224.66M | -132.08M | -131.04M | -119.03M |
| Total Depreciation and Amortization | 56.87M | 55.32M | 54.38M | 51.63M | 48.78M |
| Total Amortization of Deferred Charges | 2.90M | 2.98M | 2.97M | 2.95M | 2.93M |
| Total Other Non-Cash Items | 105.16M | 196.47M | 103.11M | 90.28M | 95.70M |
| Change in Net Operating Assets | -12.61M | -221.00K | 2.55M | 18.86M | 97.84M |
| Cash from Operations | 7.47M | 29.89M | 30.92M | 32.68M | 126.22M |
| Capital Expenditure | -29.66M | -40.61M | -47.84M | -63.35M | -65.55M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 109.00K | -69.62M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.34M | 8.32M | 9.00M | 6.42M | 12.87M |
| Cash from Investing | -24.32M | -32.29M | -38.85M | -56.82M | -122.31M |
| Total Debt Issued | 953.00K | -- | -- | -- | -- |
| Total Debt Repaid | -235.03M | -6.04M | -6.00M | -5.92M | -5.77M |
| Issuance of Common Stock | -- | -- | 312.00K | 664.00K | 664.00K |
| Repurchase of Common Stock | -2.08M | -1.83M | -1.81M | -1.78M | -684.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 443.00K | 8.81M | 8.42M | -35.40M | -55.30M |
| Cash from Financing | -235.71M | 947.00K | 921.00K | -42.44M | -61.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -252.56M | -1.45M | -7.01M | -66.58M | -57.18M |